🇨🇦 SAPHNELO in Canada

SAPHNELO (ANIFROLUMAB-FNIA) regulatory status in Canada.

Marketing authorisation

SAPHNELO in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in Canada

Frequently asked questions

Is SAPHNELO approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for SAPHNELO in Canada?

ASTRAZENECA AB is the originator. The local marketing authorisation holder may differ — check the official source linked above.